Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial.
Gong H, Tian S, Ding H, Tao L, Wang L, Wang J, Wang T, Yuan X, Heng Y, Zhang M, Shi Y, Xu C, Wu C, Wang S, Zhou L.
Gong H, et al. Among authors: tao l.
Nat Commun. 2024 Jun 19;15(1):5251. doi: 10.1038/s41467-024-49121-3.
Nat Commun. 2024.
PMID: 38898018
Free PMC article.
Clinical Trial.